141 lines
4.5 KiB
Mathematica
141 lines
4.5 KiB
Mathematica
ONCOANCF ;Hines OIFO/GWB - ACOS Reporting Paramenters ;06/14/00
|
|
;;2.11;ONCOLOGY;**1,15,25,26**;Mar 07, 1995
|
|
DATA ;
|
|
;;RECORD TYPE^1^1
|
|
;;Patient ID number^2^9
|
|
;;Registry type^10^10
|
|
;;Registry ID^11^18
|
|
;;Address at diagnosis-city^19^38
|
|
;;Address at diagnosis-state^39^40
|
|
;;County of residence at diagnosis^41^43
|
|
;;Address at diagnosis-ZIP^44^52
|
|
;;Blank^53^59
|
|
;;Marital status^60^60
|
|
;;Race^61^62^1
|
|
;;Race coding system - Current^63^63
|
|
;;Race coding system - Original^64^64
|
|
;;Spanish Surname/Origin (Ethnicity)^65^65^1
|
|
;;Sex^66^66^1
|
|
;;Age at diagnosis^67^69
|
|
;;Date of birth^70^77^1
|
|
;;Place of birth^78^80
|
|
;;Religon^81^82
|
|
;;Blank^83^106
|
|
;;Tumor record number^107^108
|
|
;;Sequence number^109^110^1
|
|
;;Date of initial diagnosis^111^118^1
|
|
;;Primary site^119^122^1
|
|
;;Laterality^123^123^1
|
|
;;Histology^124^128^1
|
|
;;Grade or differentiation^129^129^1
|
|
;;Site coding system - Current^130^130
|
|
;;Site coding system - Original^131^131
|
|
;;Morphology coding system - Current^132^132
|
|
;;Blank^133^133
|
|
;;Diagnostic confirmation^134^134^1
|
|
;;Type of reporting source^135^135
|
|
;;Accession year^136^137^1
|
|
;;Blank^138^141
|
|
;;Reporting (diagnosis) hospital^142^149
|
|
;;Accession number (hospital)^150^155^1
|
|
;;Blank^156^158
|
|
;;Date of admission^159^166
|
|
;;Date of discharge^167^174
|
|
;;Class of case^175^175^1
|
|
;;RX hospital-surgery type^176^177
|
|
;;RX hospital-radiation^178^178
|
|
;;RX hospital-chemotherapy^179^179
|
|
;;RX hospital-hormone/steroid^180^180
|
|
;;RX hospital-biological response modifier^181^181
|
|
;;RX hospital-other cancer-directed therapy^182^182
|
|
;;General Summary Stage^183^183^1
|
|
;;Local/Regional/Distant stage^184^184
|
|
;;EOD-Tumor size^185^187^1
|
|
;;EOD-Extension^188^189
|
|
;;EOD-Lymph nodes^190^190
|
|
;;Regional nodes positive^191^192^1
|
|
;;Regional nodes examined^193^194^1
|
|
;;Blank^195^213
|
|
;;T code of TNM (pathologic)^214^215^2:221,222
|
|
;;N code of TNM (pathologic)^216^217^2:223,224
|
|
;;M code of TNM (pathologic)^218^218^2:225,225
|
|
;;AJCC Stage Group (Path)^219^220^2:226,227
|
|
;;T code (Clinical)^221^222^2:214,215
|
|
;;N code (Clinical)^223^224^2:216,217
|
|
;;M code (Clinical)^225^225^2:218,218
|
|
;;AJCC Stage Group (Clinical)^226^227^2:219,220
|
|
;;TNM Edition Number^228^228
|
|
;;Distant Metastasis^229^231^1
|
|
;;Surgical Margins^232^232
|
|
;;Blank^233^236
|
|
;;Tumor Marker 1^237^237
|
|
;;Tumor Marker 2^238^238
|
|
;;Blank^239^250
|
|
;;Treatment coding system^251^251
|
|
;;RX date-surgery^252^259
|
|
;;RX date-radiation^260^267
|
|
;;RX date-chemotherapy^268^275
|
|
;;RX date-hormone/steroid therapy^276^283
|
|
;;RX date-biological response modifier^284^291
|
|
;;RX date-other cancer-directed therapy^292^299
|
|
;;RX date-started^300^307^1
|
|
;;RX summary-surgery type^308^309^1
|
|
;;Reason for no cancer-directed surgery^310^310
|
|
;;RX summary-radiation^311^311^1
|
|
;;Radiation to brain and central nervous system^312^312
|
|
;;RX summary-Radiation therapy sequence with surgery^313^313
|
|
;;RX summary-chemotherapy^314^314^1
|
|
;;RX summary-hormone/steroid (endocrine) therapy^315^315
|
|
;;RX summary-biological response modifier^316^316^1
|
|
;;RX summary-other cancer-directed therapy^317^317^1
|
|
;;Blank^318^337
|
|
;;#1 Subsequent RX-date (started)^338^345^
|
|
;;#1 Surgery^346^347^
|
|
;;#1 Radiation^348^348
|
|
;;#1 Chemotherapy^349^349
|
|
;;#1 Hormone/steroid therapy^350^350
|
|
;;#1 Biological response modifier^351^351
|
|
;;#1 Other cancer-directed therapy^352^352
|
|
;;#2 Subsequent RX-date (started)^353^360
|
|
;;#2 Surgery^361^362
|
|
;;#2 Radiation^363^363
|
|
;;#2 Chemotherapy^364^364
|
|
;;#2 Hormone/steroid therapy^365^365
|
|
;;#2 Biological response modifier^366^366
|
|
;;#2 Other cancer-directed therapy^367^367
|
|
;;#3 Subsequent RX-date (started)^368^375
|
|
;;#3 Surgery^376^377
|
|
;;#3 Radiation^378^378
|
|
;;#3 Chemotherapy^379^379
|
|
;;#3 Hormone/steroid therapy^380^380
|
|
;;#3 Biological response modifier^381^381
|
|
;;#3 Other cancer-directed therapy^382^382
|
|
;;#4 Subsequent RX-date (started)^383^390
|
|
;;#4 Surgery^391^392
|
|
;;#4 Radiation^393^393
|
|
;;#4 Chemotherapy^394^394
|
|
;;#4 Hormone/steroid therapy^395^395
|
|
;;#4 Biological response modifier^396^396
|
|
;;#4 Other cancer-directed therapy^397^397
|
|
;;Blank^398^417
|
|
;;Date of last contact^418^425^1
|
|
;;Vital status^426^426^1
|
|
;;Cancer status^427^427^1
|
|
;;Quality of survival^428^428
|
|
;;Blank^429^460
|
|
;;First recurrence-date^461^468^
|
|
;;First recurrence-type^469^469^
|
|
;;First recurrence-distant site(s)^470^472^
|
|
;;Cause of death^473^476
|
|
;;ICD revision number^477^477
|
|
;;Blank^478^481
|
|
;;Blank^482^502
|
|
;;Blank^503^522
|
|
;;ACOS coding system - Current^523^523
|
|
;;Blank^524^525
|
|
;;Vendor Name^526^535
|
|
;;AACCR Record Version^536^536
|
|
;;Blank^537^550
|
|
;;
|
|
;;
|